Fragasso Group Inc. Charles River Laboratories International, Inc. Transaction History

Fragasso Group Inc.

$1.17 Billion
Q2 2024

A detailed history of Fragasso Group Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fragasso Group Inc. holds 16,465 shares of CRL stock, worth $3.27 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

16,465

Previous 25,989 36.65%

Holding current value

$3.27 Million

Previous $7.04 Million 51.7%

% of portfolio

0.29%

Previous 0.6%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 08, 2024	SELL	$206.39 - $268.73 $1.97 Million - $2.56 Million	-9,524 Reduced 36.65%	16,465 $3.4 Million
Q1 2024 Apr 10, 2024	SELL	$203.52 - $273.43 $165,258 - $222,025	-812 Reduced 3.03%	25,989 $7.04 Million
Q4 2023 Jan 08, 2024	BUY	$164.52 - $238.84 $466,578 - $677,350	2,836 Added 11.83%	26,801 $6.34 Million
Q3 2023 Dec 06, 2023	BUY	$194.44 - $217.61 $51,526 - $57,666	265 Added 1.12%	23,965 $4.7 Million
Q2 2023 Jul 10, 2023	BUY	$183.71 - $210.25 $190,507 - $218,029	1,037 Added 4.58%	23,700 $4.98 Million
Q1 2023 Apr 13, 2023	BUY	$191.89 - $259.92 $90,380 - $122,422	471 Added 2.12%	22,663 $4.57 Million
Q4 2022 Jan 24, 2023	SELL	$197.11 - $250.07 $4.37 Million - $5.55 Million	-22,192 Closed	0 $0
Q4 2022 Jan 24, 2023	BUY	$197.11 - $250.07 $253,680 - $321,840	1,287 Added 6.16%	22,192 $0
Q3 2022 Oct 13, 2022	SELL	$182.44 - $250.54 $49,988 - $68,647	-274 Reduced 1.29%	20,905 $4.11 Million
Q2 2022 Aug 30, 2022	BUY	$204.13 - $302.4 $180,859 - $267,926	886 Added 4.37%	21,179 $4.53 Million
Q1 2022 Apr 06, 2022	SELL	$255.51 - $362.11 $249,377 - $353,419	-976 Reduced 4.59%	20,293 $5.76 Million
Q4 2021 Jan 19, 2022	SELL	$351.38 - $448.68 $444,847 - $568,028	-1,266 Reduced 5.62%	21,269 $8.01 Million
Q3 2021 Oct 08, 2021	SELL	$372.64 - $458.3 $71,546 - $87,993	-192 Reduced 0.84%	22,535 $9.3 Million
Q2 2021 Jul 19, 2021	SELL	$294.17 - $371.65 $39,418 - $49,801	-134 Reduced 0.59%	22,727 $8.41 Million
Q1 2021 May 27, 2021	BUY	$249.67 - $299.48 $66,911 - $80,260	268 Added 1.19%	22,861 $6.63 Million
Q4 2020 Feb 04, 2021	SELL	$222.0 - $252.62 $278,832 - $317,290	-1,256 Reduced 5.27%	22,593 $5.65 Million
Q3 2020 Nov 05, 2020	BUY	$175.56 - $226.45 $9,304 - $12,001	53 Added 0.22%	23,849 $5.4 Million
Q2 2020 Aug 10, 2020	SELL	$118.84 - $189.72 $254,317 - $406,000	-2,140 Reduced 8.25%	23,796 $5.27 Million
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $29,768 - $53,680	301 Added 1.17%	25,936 $3.27 Million
Q4 2019 Feb 13, 2020	BUY	$126.05 - $152.76 $67,562 - $81,879	536 Added 2.14%	25,635 $3.92 Million
Q3 2019 Nov 13, 2019	SELL	$125.07 - $143.67 $13,507 - $15,516	-108 Reduced 0.43%	25,099 $3.32 Million
Q2 2019 Aug 13, 2019	BUY	$123.4 - $148.55 $3.11 Million - $3.74 Million	25,207 New	25,207 $3.58 Million

Others Institutions Holding CRL

# of Institutions

732

Shares Held

51.8M

Call Options Held

233K

Put Options Held

236K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.

Account

Fragasso Group Inc. Charles River Laboratories International, Inc. Transaction History